Clinical utility of glycated albumin and 1,5-anhydroglucitol in the screening and prediction of diabetes: A multi-center study

Figure 3 Receiver operating characteristic curve analyses of the different models. Clinical Model 1: Body mass index (BMI), glycated hemoglobin (HbA1c), fasting plasma glucose (FPG), 2-hour glucose; Clinical Model 2: BMI, HbA1c, FPG, triglycerides; ‘B3A’ Model: BMI, HbA1c, glycated albumin, 1,5-anhydroglucitol.